OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigallocatechin-3-Gallate (EGCG): New Therapeutic Perspectives for Neuroprotection, Aging, and Neuroinflammation for the Modern Age
Ashley Payne, Samuel N. Nahashon, Equar Taka, et al.
Biomolecules (2022) Vol. 12, Iss. 3, pp. 371-371
Open Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

The Anti-Inflammatory and Immunomodulatory Activities of Natural Products to Control Autoimmune Inflammation
Kamal D. Moudgil, Shivaprasad H. Venkatesha
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 95-95
Open Access | Times Cited: 84

Oxidative stress in the eye and its role in the pathophysiology of ocular diseases
Elsa Wilma Böhm, Francesco Buonfiglio, Anna Maria Voigt, et al.
Redox Biology (2023) Vol. 68, pp. 102967-102967
Open Access | Times Cited: 63

Implications of hydrogen sulfide in colorectal cancer: Mechanistic insights and diagnostic and therapeutic strategies
Hanchao Lin, Yixin Yu, Zhu Le, et al.
Redox Biology (2023) Vol. 59, pp. 102601-102601
Open Access | Times Cited: 57

Longevity and anti-aging effects of curcumin supplementation
Mehran Izadi, Nariman Sadri, Amirhossein Abdi, et al.
GeroScience (2024) Vol. 46, Iss. 3, pp. 2933-2950
Open Access | Times Cited: 13

Neuroprotective Effects and Therapeutic Potential of the Citrus Flavonoid Hesperetin in Neurodegenerative Diseases
Jasmine A. Evans, Patricia Mendonca, Karam F. A. Soliman
Nutrients (2022) Vol. 14, Iss. 11, pp. 2228-2228
Open Access | Times Cited: 58

Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG): A Time for a New Player in the Treatment of Respiratory Diseases?
Daniela Mokrá, Jana Adamčáková, Juraj Mokrý
Antioxidants (2022) Vol. 11, Iss. 8, pp. 1566-1566
Open Access | Times Cited: 57

Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson’s disease
Yumin Wang, Shuang Wu, Qiang Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 37

NF-κB Pathway and Its Inhibitors: A Promising Frontier in the Management of Alzheimer’s Disease
Bhagavathi Sundaram Sivamaruthi, Neha R. Raghani, Mehul R. Chorawala, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2587-2587
Open Access | Times Cited: 30

Potential Synergistic Supplementation of NAD+ Promoting Compounds as a Strategy for Increasing Healthspan
Arastu Sharma, Sophie Chabloz, Rebecca A. Lapides, et al.
Nutrients (2023) Vol. 15, Iss. 2, pp. 445-445
Open Access | Times Cited: 28

Comparative Efficacy and Selectivity of Pharmacological Inhibitors of DYRK and CLK Protein Kinases
Mattias F. Lindberg, Emmanuel Deau, Jonas Arfwedson, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 6, pp. 4106-4130
Closed Access | Times Cited: 23

Phytomedicine for neurodegenerative diseases: The road ahead
Dev Madhubala, Aparup Patra, Mojibur R. Khan, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 6, pp. 2993-3019
Closed Access | Times Cited: 8

Epigallocatechin gallate suppresses mitotic clonal expansion and adipogenic differentiation of preadipocytes through impeding JAK2/STAT3-mediated transcriptional cascades
Peng He, Xiaojian Lin, Ying Wang, et al.
Phytomedicine (2024) Vol. 129, pp. 155563-155563
Closed Access | Times Cited: 7

Taming neuroinflammation in Alzheimer's disease: The protective role of phytochemicals through the gut−brain axis
Yoonsu Kim, Jinkyu Lim, Jisun Oh
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117277-117277
Closed Access | Times Cited: 6

Mitochondrial dysfunction in Alzheimer’s disease: a key frontier for future targeted therapies
Shuguang Wang, Zuning Liao, Qiying Zhang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access

Interpreting the role of epigallocatechin-3-gallate in Epstein-Barr virus infection-mediated neuronal diseases
Annu Rani, Vaishali Saini, Nfor Gael Njini, et al.
Folia Microbiologica (2025)
Closed Access

Quantitative analysis of epigallocatechin-3-gallate in treating renal injury via meta-analysis and machine learning
Jie Chen, Jianniao Tian, Yuanhao Zhang, et al.
Phytochemistry Reviews (2025)
Closed Access

Recent advancements in the understanding of the alterations in mitochondrial biogenesis in Alzheimer’s disease
Shreya Singh, Rakesh Kumar Singh
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access

Natural products against tau hyperphosphorylation‐induced aggregates: Potential therapies for Alzheimer's disease
Gustavo Basurto‐Islas, Mario Dı́az, Lizeth M. Zavala Ocampo, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 1
Open Access

Molecular Mechanisms of the Anti-Inflammatory Effects of Epigallocatechin 3-Gallate (EGCG) in LPS-Activated BV-2 Microglia Cells
Ashley Payne, Equar Taka, Getnet Mequanint Adinew, et al.
Brain Sciences (2023) Vol. 13, Iss. 4, pp. 632-632
Open Access | Times Cited: 17

Tea polyphenols: extraction techniques and its potency as a nutraceutical
Horia Shaukat, Anwar Ali, Yang Zhang, et al.
Frontiers in Sustainable Food Systems (2023) Vol. 7
Open Access | Times Cited: 16

Page 1 - Next Page

Scroll to top